Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Maria Jesus Perez-Elias"'
Autor:
Helen Dolengevich-Segal, Alicia Gonzalez-Baeza, Jorge Valencia, Eulalia Valencia-Ortega, Alfonso Cabello, Maria Jesus Tellez-Molina, Maria Jesus Perez-Elias, Regino Serrano, Leire Perez-Latorre, Luz Martin-Carbonero, Sari Arponen, Jose Sanz-Moreno, Sara De la Fuente, Otilia Bisbal, Ignacio Santos, Jose Luis Casado, Jesus Troya, Miguel Cervero-Jimenez, Sara Nistal, Guillermo Cuevas, Javier Correas-Lauffer, Marta Torrens, Pablo Ryan, U-SEX GESIDA 9416 Study
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0220272 (2019)
OBJECTIVES:Sexualized intravenous drug use, also known as slamsex, seems to be increasing among HIV-positive men who have sex with men (MSM). Physical and psychopathological symptoms have previously been reported in this population, although research
Externí odkaz:
https://doaj.org/article/8b7c16b03255423baf7d2467eeaef1b8
Autor:
Juan González del Castillo, Maria Jesus Perez Elias, Iría Miguens, Begoña Espinosa, Ricardo Juárez, Lourdes Piedrafita Lozoya, Patricia Trenc, Jesus Alvarez Manzanares, María José Marchena, Raquel Rodríguez, Nayra Cabrera, Pilar Grajal, Carmen Navarro, Pascual Piñera, Federico García, Santiago Moreno, Oscar Miro
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::164b566de93b7266ffe08132f4feb7bd
https://doi.org/10.1016/j.eimc.2023.03.004
https://doi.org/10.1016/j.eimc.2023.03.004
Autor:
Maria Jesus, Perez Elias, Belen, Alejos, Maria Mar, Gutierrez, Manuel, Crespo, Ignacio, De Los Santos Gil, Esteve, Ribera, Maria Jose, Galindo, Fernando, Lozano, Antonio, Payeras Cifre, Vicente, Boix, Marta, Montero-Alonso, José, Sanz, Javier, De La Torre Lima, Rosario, Palacios, Sara, De La Fuente Moral, Esteban, Martinez, María, Yllescas
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:1046-1050
BackgroundCobicistat, dolutegravir and rilpivirine are all modest inhibitors of proximal tubular creatinine secretion (IPTCrS) and hence a moderate and early non-progressive creatinine estimated glomerular filtration rate (Cr-eGFR) reduction has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9e60be74548f8a9d623c3bb42cecd1
https://doi.org/10.1093/jac/dkaa547
https://doi.org/10.1093/jac/dkaa547
Autor:
Jean-Michel Molina, Kathleen Squires, Paul E Sax, Pedro Cahn, Johan Lombaard, Edwin DeJesus, Ming-Tain Lai, Anthony Rodgers, Lisa Lupinacci, Sushma Kumar, Peter Sklar, George J Hanna, Carey Hwang, Elizabeth Anne Martin, Debbie P. Hagins, Olayemi O. Osiyemi, David James Prelutsky, Moti N. Ramgopal, Anthony John Scarsella, Robin Dretler, Christopher J. Bettacchi, James Sims, Patrick G. Clay, Nicholaos C. Bellos, Melanie A. Thompson, Jose Montero, Cheryl K. McDonald, Catherine Creticos, David Shamblaw, Miguel Mogyoros, Antonio E. Terrelonge, Martin Valdes, Karen T. Tashima, William J. Robbins, Franco Antonio Felizarta, Richard A. Elion, Jihad Slim, Sandra S. Win, Sujata N. Lalla-Reddy, Peter Jerome Ruane, Anthony Mills, Jerry L. Cade, Craig A. Dietz, David Scott Rubin, Cynthia Mayer, Juan Carlos Rondon, Paul P. Cook, Eric Daar, Princy N. Kumar, Susan Swindells, Jose Guillermo Castro, Ivan Melendez-Rivera, Javier O. Morales-Ramirez, Lizette Santiago, Jorge L. Santana-Bagur, Marcelo Martins, Pedro Enrique Cahn, Gustavo D. Lopardo, Norma Porteiro, Mark Theo Bloch, David Alfred Baker, Norman Roth, Richard James Moore, Robert James Finlayson, James McMahon, Armin Rieger, Alexander Zoufaly, Sylvia Hartl, Robert Zangerle, Fiona Smaill, Sharon L. Walmsley, Brian Conway, Anita Rachlis, Graham H.R. Smith, Carlos Perez, Alejandro Afani, Maria Isabel Campos, Carolina Eugenia Chahin, Marcelo Wolff Reyes, Jan Gerstoft, Nina Weis, Alex Lund Laursen, Yazdan Yazdanpanah, Laurent Cotte, Francois Raffi, Philippe Morlat, Pierre-Marie Girard, Christine Katlama, Juergen K. Rockstroh, Keikawus Arasteh, Stefan Esser, Albrecht Stoehr, Hans-Juergen Stellbrink, Matthias Stoll, Dirk Schuermann, Gerd Faetkenheuer, Johannes Bogner, Thomas Lutz, Axel Baumgarten, Hans Jaeger, Andrea Gori, Gabriel Coltan, Felicia Constandis, Simona Manuela Erscoiu, Liviu-Jany Prisacariu, Sorin Rugina, Adrian Streinu-Cercel, Vadim Valentinovich Pokrovsky, Natalia V. Zakharova, Andrey Anatolyevich Shuldyakov, Elena Pavlovna Ryamova, Valeriy Viktorovich Kulagin, Olga Aleksandrovna Tsybakova, Elena Orlova-Morozova, Firaya Nagimova, Evgeniy Voronin, Tatyana Evgenyevna Shimonova, Oleg Anatolyevich Kozyrev, Catherine Orrell, Johannes Jurgens Lombaard, Marleen de Jager, Joaquin Portilla Segorb, Josep Mallolas, Maria Jesus Perez Elias, Josep M. Gatell, Jose Ramon Arribas Lopez, Eugenia Negredo Puigmal, Daniel Podzamczer Palter, Federico Pulido Ortega, Jesus Troya Garcia, Ignacio De los Santos Gil, Juan Berenguer Berenguer, Ian G. Williams, Margaret A. Johnson, Gabriel Schembri, Amanda Clarke, Mark Gompels, Julie Meriel Fox, Steven John Taylor, David Harold Dockrell, Stephen Kegg
Publikováno v:
The Lancet HIV. 7:e16-e26
Doravirine is a novel, non-nucleoside reverse transcriptase inhibitor that has shown non-inferior efficacy to ritonavir-boosted darunavir, with a superior lipid profile, in adults with HIV who were treatment naive at week 48 in the phase 3 DRIVE-FORW
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8680b3078cd4f9be32d8a00724f02a77
https://doi.org/10.1016/s2352-3018(19)30336-4
https://doi.org/10.1016/s2352-3018(19)30336-4
Autor:
E Schuelter, Schlomo Staszewski, Karl Hesse, Julio Montaner, Gerardo Alvarez-Uria, Stefano Vella, Peter Reiss, Dolphina Cogill, Colette Smith, Gaston Picchio, Christopher J. Hoffmann, Hugo Tempelman, Gordana Dragovic, Maurizio Zazzi, Laura Monno, Maria-Jesus Perez-Elias, Julio S. G. Montaner, Omar Sued, Adrian Streinu-Cercel, Raph L Hamers, Robin Wood, Lidia Ruiz, J A Metcalf, Brian Gazzard, Sundhiya Mandalia, Emanuel Vlahakis, Raph L. Hamers, Shanmugam Saravanan, Juan Sierra Madero, Kim C. E. Sigaloff, Cliff Lane, Brian K. Agan, José M. Gatell, Richard Harrigan, Ricardo Sobhie Diaz, Brendan Larder, Anton Pozniak, Vincent C. Marconi, Pachamuthu Balakrishnan, Wataru Sugiura, David A. Cooper, Andrew Carr, Richard Norris, Roos Barth, Tobias F. Rinke de Wit, Carina Cesar, Gabrielle Dettorre, Sean Emery, Scott Wegner, John D. Baxter, Dechao Wang, Elisa de Lazzari, H. Clifford Lane, Federico García, Carl Morrow, Catherine A Rehm, Rolf Kaiser, Lotty Ledwaba, Paul Khabo, Marie-Pierre deBethune, Cecilia Sucupira, Bonventura Clotet, Luminita Ene, Andrew D. Revell, Ard van Sighem, Mark T. Nelson, Bonaventura Clotet, Tulio de Oliveira, Carlo Torti
Publikováno v:
J Antimicrob Chemother
ObjectivesWith the goal of facilitating the use of HIV-TRePS to optimize therapy in settings with limited healthcare resources, we aimed to develop computational models to predict treatment responses accurately in the absence of commonly used baselin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5765537e3e01082e500c1960b1b38b31
https://europepmc.org/articles/PMC8212763/
https://europepmc.org/articles/PMC8212763/
Autor:
Bonaventura Clotet, Ard van Sighem, Mark T. Nelson, Peter Reiss, H. Clifford Lane, Gerardo Alvarez-Uria, Hugo Tempelman, Maria-Jesus Perez-Elias, Dechao Wang, Julio S. G. Montaner, Andrew D. Revell, Robin Wood, Brendan Larder
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 81(2), 207-215. Lippincott Williams and Wilkins
OBJECTIVE: Definitions of virological response vary from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e19527d7f3e16481e5fd7b34fb9544
https://pure.amc.nl/en/publications/predicting-virological-response-to-hiv-treatment-over-time-a-tool-for-settings-with-different-definitions-of-virological-response(9ab78e51-2782-4d48-b3ef-a993c7b9f917).html
https://pure.amc.nl/en/publications/predicting-virological-response-to-hiv-treatment-over-time-a-tool-for-settings-with-different-definitions-of-virological-response(9ab78e51-2782-4d48-b3ef-a993c7b9f917).html
Autor:
Alejandro G. García-Ruiz de Morales, María Jesús Vivancos, Jorge Lázaro, Beatriz Romero Hernández, Beatriz Mateos, Pilar Pérez-Elías, Margarita Herrero Delgado, Laura Villanova Cuadra, Santiago Moreno, Javier Martínez-Sanz, María Jesús Pérez-Elías
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1846 (2024)
Despite remarkable improvement in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) care continuum, the rate of late diagnosis of HIV and HCV in high-income countries remains unacceptably high. Testing relies mainly on primary care p
Externí odkaz:
https://doaj.org/article/bd96d538550841f99b0ad787b3d3de48
Autor:
Elena Moreno, Javier Martínez-Sanz, Rosa Martín-Mateos, Jorge Díaz-Álvarez, Sergio Serrano-Villar, Diego Burgos-Santamaría, Laura Luna, María Jesús Vivancos, Ana Moreno-Zamora, María Jesús Pérez-Elías, Santiago Moreno, Fernando Dronda, María Luisa Montes, Matilde Sánchez-Conde
Publikováno v:
BMC Genomics, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a comorbidity that generally increases in people living with HIV (PLWH). This condition is usually accompanied by persistent inflammation and premature immune system aging. In t
Externí odkaz:
https://doaj.org/article/9d1c65e7a17b4287907c03b2f6ce9323
Autor:
Javier Martínez-Sanz, Manuel Ponce-Alonso, Laura Martínez-García, Víctor de la Cueva, Leticia Olavarrieta, Laura Montero, María Jesús Pérez-Elías, Juan Carlos Galán
Publikováno v:
International Journal of Infectious Diseases, Vol 137, Iss , Pp 111-113 (2023)
Several possible mpox reinfections have been reported, however, the debate on whether these are confirmed reinfections remains open.A 30-year-old male living with HIV and a history of single-dose mpox vaccination, first diagnosed with mpox in Septemb
Externí odkaz:
https://doaj.org/article/b81ec94238d547deba07535bcac42e38
Autor:
Luminita Ene, Shanmugam Saravanan, Andrew D. Revell, E Schuelter, Julio S. G. Montaner, Catherine A Rehm, Brian K. Agan, Peter Reiss, Tobias F. Rinke de Wit, Robin Wood, Maurizio Zazzi, David A. Cooper, Elisa de Lazzari, Carina Cesar, Ricardo Sobhie Diaz, Brendan Larder, Gerardo Alvarez-Uria, Rdi Data, Scott Wegner, J A Metcalf, Gordana Dragovic, H. Clifford Lane, Carlo Torti, Roos Barth, Gaston Picchio, Dechao Wang, Omar Sued, Richard Harrigan, Stefano Vella, John D. Baxter, Richard Norris, Marie-Pierre deBethune, Ard I van Sighem, Lidia Ruiz, Julio Montaner, Anton Pozniak, Schlomo Staszewski, Brian Gazzard, Bonaventura Clotet, Sundhiya Mandalia, Juan Sierra Madero, Bonventura Clotet, Lotty Ledwaba, Cliff Lane, Wataru Sugiura, Adrian Streinu-Cercel, Andrew Carr, Kim C. E. Sigaloff, José M. Gatell, Dolphina Cogill, Hugo Tempelman, Karl Hesse, Vincent C. Marconi, Raph L Hamers, Colette Smith, Rolf Kaiser, Gabrielle Dettorre, Carl Morrow, Pachamuthu Balavskrishnan, Tulio de Oliveira, Sean Emery, Cecilia Sucupira, Laura Monno, Emanuel Vlahakis, Raph L. Hamers, Paul Khabo, Chris Hoffmann, Ard van Sighem, Mark T. Nelson, Maria-Jesus Perez-Elias
Publikováno v:
Journal of antimicrobial chemotherapy, 73(8), 2186-2196. Oxford University Press
Objectives Optimizing antiretroviral drug combination on an individual basis can be challenging, particularly in settings with limited access to drugs and genotypic resistance testing. Here we describe our latest computational models to predict treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb0b2b20ef76c760d2eb547fed68117d
https://pubmed.ncbi.nlm.nih.gov/29889249
https://pubmed.ncbi.nlm.nih.gov/29889249